Oncology & Cancer

Early treatment may prevent progression to multiple myeloma

Early intervention with an immunotherapy-based drug combination may prevent progression of high-risk "smoldering" multiple myeloma to the full-blown disease, according to researchers from Dana-Farber Cancer Institute.

Oncology & Cancer

Drug trio shows major promise against myeloma

(HealthDay)—Adding a newer drug to a standard treatment for advanced cases of multiple myeloma may significantly boost patients' chances of a response and even recovery, a new clinical trial finds.

Oncology & Cancer

As body mass index increases, so does spread of multiple myeloma

In a new study published in Cancer Letters, American University researchers show how, as body mass index increases, so does the growth and spread of the blood cancer multiple myeloma, which accounts for about 10 percent of ...

Medical research

Scientists discover mechanism of thalidomide

In the 1950s, thalidomide (Contergan) was prescribed as a sedative drug to pregnant women, resulting in a great number of infants with serious malformations. Up to now, the reasons for these disastrous birth defects have ...

page 6 from 19